Sheldon L. Koenig
Director, President and CEO · 3 filings · Latest: Jun 17, 2026
Esperion Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ESPR | Sheldon L. Koenig | Director, President and CEO | Jun 17, 2026 | Sale | $3.16 | 53,588 | $169.1K | 2,119,111 | |
ESPR | Koenig Sheldon L. | — | Jun 17, 2026 | Proposed Sale | $3.15 | 53,588 | $169.1K | — | |
ESPR | Sheldon L. Koenig | Director, President and CEO | Mar 17, 2026 | Sale | $2.72 | 25,578 | $69.5K | 2,172,699 | |
ESPR | Koenig Sheldon L. | — | Mar 17, 2026 | Proposed Sale | $2.72 | 25,578 | $69.6K | — | |
ESPR | Koenig Sheldon L. | — | Dec 17, 2025 | Proposed Sale | $3.67 | 48,244 | $177.2K | — | |
ESPR | Koenig Sheldon L. | — | Sep 17, 2025 | Proposed Sale | $2.79 | 28,427 | $79.2K | — | |
ESPR | Koenig Sheldon L. | — | Jun 17, 2025 | Proposed Sale | $1.11 | 30,474 | $33.8K | — | |
ESPR | Koenig Sheldon L. | — | Mar 18, 2025 | Proposed Sale | $1.50 | 13,047 | $19.6K | — | |
ESPR | Koenig Sheldon L. | — | Dec 17, 2024 | Proposed Sale | $2.47 | 12,447 | $30.7K | — | |
ESPR | Koenig Sheldon L. | — | Sep 17, 2024 | Proposed Sale | $1.80 | 14,550 | $26.1K | — |